Kidney Transplant Outcomes in Patients with and without Type II Diabetes Mellitus
Cardiorenal Medicine · 04.04.2026 · 16 (1) · 237-247
DOI: 10.1159/000551839 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiorenal Medicine, online erschienen am 04.04.2026. Verfasst von Jan H N Lindeman und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery and Leiden Transplant Center, Leiden University Medical Center, Leiden, The Netherlands, lindeman@lumc.nl. Hauptthemen laut MEDLINE: Kidney Transplantation, Diabetes Mellitus, Type 2, Kidney Failure, Chronic. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Introduction
This study aimed to estimate the impact of type II diabetes (DM-II) on kidney transplant outcomes and graft utility.
Methods
A nationwide, registry-based study compares outcomes for all primary kidney transplantations performed between 2000 and 2022 in the Netherlands in DM-II patients (761 deceased and 364 living donor procedures) with nondiabetic controls.
Results
Short-term (≤90 days) transplant outcomes for living donor procedures were similar for DM-II and nondiabetic controls. Deceased donor transplantations in DM-II patients were associated with an increased incidence of delayed graft function (p < 0.0002), and a doubling of 90-day mortality (HR: 2.19 [95% CI: 1.49–3.23], p < 0.0001). Evaluation of long-term graft survival, with death as competing risk, indicated an equal (sub-distribution hazard rate [sHR] 0.95 [0.74–1.23]), respectively, compromised (sHR 1.91 [1.37–2.65]; p < 0.001) survival for grafts from deceased or living donors. DM-II profoundly impacted recipient survival (HR for death, respectively, 1.63 [1.45–1.82] and 1.81 [1.51–2.17]; p < 0.001) for recipients of a deceased or living donor graft (nondiabetic recipient is reference), with cardiovascular event and infection as dominant causes of death. The compromised recipient survival profoundly impacted the utility of kidney transplantations (p < 0.001).
Conclusions
Despite excellent graft survival, the efficacy of kidney transplantations in DM-II patients is compromised by reduced recipient survival. Cause of death distribution suggests a role for immunosuppressive regimens in the excess mortality observed. A shift in focus from optimized transplant to optimized patient survival is warranted for DM-II patients. Moreover, the conflict between increasing incidences of DM-II, a lower transplant utility, but persistent donor organ shortages, calls for development of novel organ allocation strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery and Leiden Transplant Center, Leiden University Medical Center, Leiden, The Netherlands, lindeman@lumc.nl.
- Department of Surgery and Leiden Transplant Center, Leiden University Medical Center, Leiden, The Netherlands.
- Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
- Department of Internal Medicine (Nephrology), Amsterdam UMC, Academic Medical Center, Amsterdam, The Netherlands.
- Department of Internal Medicine (Nephrology), University Medical Center Groningen, Groningen, The Netherlands.
- Department of Internal Medicine (Nephrology), Maastricht University Medical Center, Maastricht, The Netherlands.
Zitieren
APA
Lindeman, J. H. N., Ploeg, R. J., Sharples, E., Alwayn, I. P., Bemelman, F. J., Berger, S. P., Christiaans, M. H. L., Konijn, C., de Vries, A. P. J., van de Wetering, J., van Zuilen, A. D., Hunter, J. P., Touwen, D. P., Bastiaannet, E., & Schaapherder, A. F. M. (2026). Kidney Transplant Outcomes in Patients with and without Type II Diabetes Mellitus. Cardiorenal Medicine, 16(1), 237-247. https://doi.org/10.1159/000551839
Vancouver
Lindeman JHN, Ploeg RJ, Sharples E, Alwayn IP, Bemelman FJ, Berger SP, et al. Kidney Transplant Outcomes in Patients with and without Type II Diabetes Mellitus. Cardiorenal Medicine. 2026;16(1):237-247. doi:10.1159/000551839
BibTeX
@article{Lindeman2026,
author = {Lindeman, Jan H N and Ploeg, Rutger J and Sharples, Edward and Alwayn, Ian P and Bemelman, Frederieke J and Berger, Stefan P and Christiaans, Maarten H L and Konijn, Cynthia and de Vries, Aiko P J and van de Wetering, Jacqueline and van Zuilen, Arjan D and Hunter, James P and Touwen, Dorothea P and Bastiaannet, Esther and Schaapherder, Alexander F M},
title = {Kidney Transplant Outcomes in Patients with and without Type II Diabetes Mellitus},
journal = {Cardiorenal Medicine},
year = {2026},
volume = {16},
number = {1},
pages = {237--247},
doi = {10.1159/000551839}
}
EUVIMED